You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 7, February 15, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •Full text
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Metabolic Diseases
 •JAMA Patient Page
 •Alert me on articles by topic

The Metabolic Syndrome

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Since cardiovascular (heart and blood vessel) disease is the leading cause of death for adults in developed countries, many medical studies focus on treating or preventing heart disease and stroke. The metabolic syndrome, a collection of unhealthy body measurements and abnormal laboratory test results, may identify persons at high risk for developing cardiovascular disease. Aggressive lifestyle modification and possible use of medications to treat the conditions that make up the metabolic syndrome may reduce a person's chances of developing heart disease or stroke. The metabolic syndrome has also been called syndrome X or insulin resistance syndrome. The February 15, 2006, issue of JAMA includes an article about the metabolic syndrome.

DEFINITION OF THE METABOLIC SYNDROME

  • Abdominal (waist) circumference greater than 40 inches for men or 35 inches for women
  • High blood pressure (hypertension)
  • Hyperglycemia (fasting blood sugar more than 110 mg/dL)
  • Elevated triglycerides (a type of fat in the bloodstream)
  • Low levels of high-density . . . [Full Text of this Article]

Janet M. Torpy, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor


RELATED ARTICLE

Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Priya Kohli and Philip Greenland
JAMA. 2006;295(7):819-821.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.